2015 | A multicenter, prospective, longitudinal registry of prostate cancer in Asia | Uemura, H.; Ye, D.; Wu, T-L.; Lee, J-Y.; Chong, Y. L.; Razack, A. H. A.; Pripatnanont, C.; Chiong, E.; Lau, W. K. O.; Kanesvaran, R.; Li, C.; Rawal, S.; Tongaonkar, H.; Pu, Y-S.; Santingamkun, A.; Lojanapiwat, B.; Liang, H.; Mah, K. W.; Losio, M. van Kooten; Liu, Y.; 蒲永孝 | Ann. Oncol. | | | |
2016 | Efficacy, safety and pharmacokinetics (PK) of enzalutamide (ENZ) vs placebo (PL) in chemotherapy-naive patients (pts) with progressive metastatic castration-resistant prostate cancer (mCRPC): An Asian multinational study | Ye, D.; Ahn, H.; Pu, Y-S.; Han, W.; Xie, L-P.; Huang, S-P.; Wu, H-C.; Ma, L.; Qi, J.; Zhou, F.; Sun, G.; Chen, L.; Xue, B.; Yamada, S.; Saito, M.; Suga, K.; Sun, Y.; 蒲永孝 | Ann. Oncol. | | | |